Pricing
  1. US-listed companies
  2. Arcadia Biosciences, Inc.
  3. Financials
  4. Total liabilities

Arcadia Biosciences, Inc. (RKDA)

Market cap
$2.52M
P/E ratio
SummaryFinancials
Period EndTotal liabilities (Million USD)YoY (%)
Dec 31, 20247+4.17%
Dec 31, 20237-12.72%
Dec 31, 20228-36.94%
Dec 31, 202113-32.32%
Dec 31, 202019-22.48%
Dec 31, 201924+116.33%
Dec 31, 201811+30.90%
Dec 31, 20179-75.09%
Dec 31, 201634+1.06%
Dec 31, 201534

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat